CO2Lift Topical Carboxytherapy Gets Oxford Spotlight

CO2Lift, Lumisque’s topical carboxytherapy platform, was presented at the Oxford World Conference on Sept. 4-5 at Magdalen College in Oxford before about 35 physicians focused on regenerative medicine. The appearance gave Lumisque a platform to position CO2Lift as a distinct category in regenerative care and support its physician education push.

Why it matters: - CO2Lift’s Oxford presentation gave Lumisque an international stage to argue that topical carboxytherapy should be viewed as a category of its own in regenerative medicine. - The company is using physician education and clinical collaboration to build awareness of CO2Lift across aesthetic and regenerative treatment settings. - The presentation also signals Lumisque’s effort to expand how regenerative medicine is discussed, with more attention on the treatment environment and recovery.

What happened: - Dr. Martha Gabriela Serrano presented CO2Lift-related protocol work at the Oxford World Conference on Sept. 4-5 at Magdalen College in Oxford. - The meeting brought together about 35 physicians from around the world. - The conference focused on advancing protocols and technologies in regenerative medicine. - Serrano presented a protocol using carboxytherapy in patients undergoing gynecological oncological vulvar surgery. - Lumisque said the presentation marked a milestone in its effort to establish topical carboxytherapy as a distinct category rather than a single product.

The details: - CO2Lift is Lumisque’s flagship topical carboxytherapy technology. - The system uses a two-component topical gel that generates carbon dioxide at the treatment site through a controlled chemical reaction. - The technology is designed as a non-invasive topical carboxytherapy approach. - Medical and aesthetic professionals use CO2Lift across multiple treatment protocols. - Serrano said the meeting was a strong opportunity to share clinical experience with a focused international group of physicians. - Serrano said CO2Lift was recognized in the top 10 technologies at the meeting. - Lana Kerr, founder and CEO of Lumisque, said the Oxford recognition was an important moment for CO2Lift and for the science behind the platform.

Between the lines: - Lumisque is trying to move CO2Lift beyond product marketing and into a broader professional framework centered on regenerative care. - The Oxford setting lends credibility because the audience was small, highly specialized and international. - The company’s emphasis on recovery environment suggests it wants CO2Lift used alongside procedures, not only as a standalone add-on. - This framing may help Lumisque differentiate CO2Lift in a crowded regenerative and aesthetic market.

What’s next: - Lumisque said it will continue investing in physician education, clinical collaboration and international awareness around topical carboxytherapy. - The company is working to build greater scientific and professional understanding of where topical carboxytherapy fits in treatment protocols. - Lumisque plans to keep positioning CO2Lift in professional aesthetic and regenerative settings.

The bottom line: - CO2Lift’s Oxford appearance was less about a product launch and more about category-building, with Lumisque pushing topical carboxytherapy as a distinct tool in regenerative care.

More information: CO2Lift on Instagram